75000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Consolidated Statements of Financial Position
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Consolidated Statements of Loss and Comprehensive Loss
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Consolidated Statements of Changes in Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995457 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance
link:presentationLink
link:calculationLink
link:definitionLink
995467 - Disclosure - Nature of Operations and Going Concern
link:presentationLink
link:calculationLink
link:definitionLink
995477 - Disclosure - Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995487 - Disclosure - Material Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995497 - Disclosure - Adoption of New Accounting Standards
link:presentationLink
link:calculationLink
link:definitionLink
995507 - Disclosure - Critical Accounting Estimates And Judgements
link:presentationLink
link:calculationLink
link:definitionLink
995517 - Disclosure - Acquisition of BioStrand
link:presentationLink
link:calculationLink
link:definitionLink
995527 - Disclosure - Investment
link:presentationLink
link:calculationLink
link:definitionLink
995537 - Disclosure - Property and Equipment (Including Right of Use Assets)
link:presentationLink
link:calculationLink
link:definitionLink
995547 - Disclosure - Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
995557 - Disclosure - Goodwill
link:presentationLink
link:calculationLink
link:definitionLink
995567 - Disclosure - Convertible Debentures
link:presentationLink
link:calculationLink
link:definitionLink
995577 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995587 - Disclosure - Share Capital
link:presentationLink
link:calculationLink
link:definitionLink
995597 - Disclosure - Employee Remuneration
link:presentationLink
link:calculationLink
link:definitionLink
995607 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995617 - Disclosure - Capital Management
link:presentationLink
link:calculationLink
link:definitionLink
995627 - Disclosure - Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
995637 - Disclosure - Inventories
link:presentationLink
link:calculationLink
link:definitionLink
995647 - Disclosure - Commitments
link:presentationLink
link:calculationLink
link:definitionLink
995657 - Disclosure - Grant and Subsidy Income
link:presentationLink
link:calculationLink
link:definitionLink
995667 - Disclosure - Segmented Information and Economic Dependence
link:presentationLink
link:calculationLink
link:definitionLink
995677 - Disclosure - Supplemental Cash Flow Information
link:presentationLink
link:calculationLink
link:definitionLink
995687 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995697 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995707 - Disclosure - Material Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995717 - Disclosure - Basis of Presentation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995727 - Disclosure - Material Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995737 - Disclosure - Acquisition of IPA Europe (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995747 - Disclosure - Acquisition of Biostrand (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995757 - Disclosure - Property and Equipment (Including Right of Use Assets) (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995767 - Disclosure - Intangibles assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995777 - Disclosure - Goodwill (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995787 - Disclosure - Convertible Debentures (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995797 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995807 - Disclosure - Share Capital (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995817 - Disclosure - Employee Remuneration (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995827 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995837 - Disclosure - Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995847 - Disclosure - Inventories (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995857 - Disclosure - Segmented Information and Economic Dependence (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995867 - Disclosure - Supplemental Cash Flow Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995877 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995887 - Disclosure - Nature of Operations and Going Concern - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995897 - Disclosure - Basis of Presentation - Summary of Subsidiaries which are Wholly Owned and Subject to Control (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995907 - Disclosure - Basis of Presentation - Summary of Income from Discontinued Operations, Net of Tax (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995917 - Disclosure - Basis of Presentation - Summary of Financial Position Reclassified to Discontinued Operations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995927 - Disclosure - Material Accounting Policies - Summary of Classification and Measurement of Financial Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995937 - Disclosure - Material Accounting Policies - Summary of Revenue Recognized Over Time Versus at Point in Time (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995947 - Disclosure - Material Accounting Policies - Schedule of Estimated Term of Asset (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995957 - Disclosure - Material Accounting Policies - Summary of Amortization of Intangible Assets with Finite Lives (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995967 - Disclosure - Material Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995977 - Disclosure - Critical Accounting Estimates And Judgments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995987 - Disclosure - Acquisition of IPA Europe - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995997 - Disclosure - Acquisition of IPA Europe - Summary of Changes in Value of Deferred Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996007 - Disclosure - Acquisition of Biostrand - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996017 - Disclosure - Acquisition of Biostrand - Summary of Allocated Purchase Price (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996027 - Disclosure - Acquisition of Biostrand - Summary of Changes in Value of Subsequent Payments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996037 - Disclosure - Investment - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996047 - Disclosure - Property and Equipment (Including Right of Use Assets) - Summary of Changes in the Value of Property and Equipment and Right-of-use Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996057 - Disclosure - Intangibles Assets - Summary of Changes in the Value of the Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996067 - Disclosure - Intangibles Assets - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996077 - Disclosure - Goodwill - Schedule of Reconciliation of Changes in Goodwill Explanatory (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996087 - Disclosure - Goodwill - Schedule of Tabular Form of Allocating Goodwill to Cash Generating Units (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996097 - Disclosure - Goodwill - Schedule of Information for Individual Asset or Cash generating Unit (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996107 - Disclosure - Goodwill - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996117 - Disclosure - Convertible Debentures - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996127 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996137 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Related to Equipment under Finance Lease and Office Lease Obligation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996147 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Related to Equipment under Finance Lease and Office Lease Obligation (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996157 - Disclosure - Leases - Schedule of Disclosure in Tabular Form of Nature of Companies Leases (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996167 - Disclosure - Leases - Schedule of Changes in the Value of the Right-of-Use Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996177 - Disclosure - Leases - Schedule of Disclosure in Tabular Form Of Expenses Relating to Payments not included (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996187 - Disclosure - Share Capital - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996197 - Disclosure - Share Capital - Summary of Stock Option Awards (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996207 - Disclosure - Share Capital - Summary of Stock Option Awards (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996217 - Disclosure - Share Capital - Summary of Changes in Stock Option (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996227 - Disclosure - Share Capital - Summary of Options Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996237 - Disclosure - Share Capital - Summary of Options Outstanding (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996247 - Disclosure - Share Capital - Summary of Changes in Warrants and Finder's Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996257 - Disclosure - Share Capital - Details of Warrants and Finder's Warrants Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996267 - Disclosure - Share Capital - Details of Warrants and Finder's Warrants Outstanding (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996277 - Disclosure - Share Capital - Summarizes Activity Related to RSUs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996287 - Disclosure - Employee Remuneration - Summary of Expenses Recognized for Employee Wages, Salaries and Benefits (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996297 - Disclosure - Related Party Transactions - Schedule of Compensation For Key Management (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996307 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996317 - Disclosure - Capital Management - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996327 - Disclosure - Financial Instruments - Schedule of Details of Amounts Receivable and Allowances for Credit Losses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996337 - Disclosure - Financial Instruments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996347 - Disclosure - Financial Instruments - Schedule of Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996357 - Disclosure - Financial Instruments - Schedule of Contractual Cash Flow Requirements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996367 - Schedule - Inventories - Summary of Detailed Information About Inventories (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996377 - Disclosure - Inventories - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996387 - Disclosure - Commitments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996397 - Disclosure - Grant and Subsidy Income - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996407 - Disclosure - Segmented Information and Economic Dependence - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996417 - Disclosure - Segmented Information and Economic Dependence - Summary of Geographical Segments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996427 - Disclosure - Segmented Information and Economic Dependence - Summary of Revenues Allocated According to Revenue Types (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996437 - Disclosure - Supplemental Cash Flow Information - Summary of Non-cash Investing and Financing Transactions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996447 - Disclosure - Supplemental Cash Flow Information - Summary of Changes in Liabilities Arose From Financing Activities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996457 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996467 - Disclosure - Income Taxes - Summary of Differences and Related Tax Rate (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996477 - Disclosure - Income Taxes - Summary of Temporary Differences to Deferred Income Tax Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996487 - Disclosure - Income Taxes - Summary of Temporary Differences to Deferred Income Tax Assets and Liabilities (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996497 - Disclosure - Income Taxes - Summary of Temporary Differences to Deferred Income Tax Assets and Liabilities (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996507 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
999009 - Disclosure - Anchoring
link:presentationLink
link:calculationLink
link:definitionLink
Cash outflow for leases
Cash outflow for leases
Financial assets, Classification and measurement IFRS 9
Financial assets, measurement category immediately after initial application of IFRS 9
Summary of Changes in Finder's Warrants
Disclosure Of Changes In Finders Warrants Explanatory
Disclosure of changes in Finders Warrants.
Prepaid expenses
Current prepaid expenses
Accounts payable and accrued liabilities
Current Accounts Payable And Accrued Liabilities
Current accounts payable and accrued liabilities.
Disclosure of detailed information about business combination [abstract]
Disclosure Of Income Taxes [Table]
Disclosure Of Income Taxes [Table]
Disclosure of income taxes.
Top of range [member]
Top of Range
Non-cash changes, Foreign exchange movements and change in estimates
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Entity Incorporation, State or Country Code
Decrease Through Discontinued Operations, Right-of-use Assets
Decrease through discontinued operations, right-of-use assets.
Discontinued operations
Weighted average life remaining (years)
Weighted Average Life Remaining Class Of Warrants
Weighted average life remaining, class of warrants.
Recoverable amount
Recoverable amount of asset or cash-generating unit
Entity Current Reporting Status
Option Eight [Member]
Option eight.
Option Expiry Date May 8, 2033
Increase (decrease) through share-based payment transactions, equity
Share-based expense
Net assets (liabilities)
Net
Assets (liabilities)
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Grant From Government [Axis]
Grant From Government
Revenue Expense From Government Grants
Grant income
Revenue (expense) from government grants.
Payments of lease liabilities
Payments of lease liabilities, classified as financing activities
Repayment of principal on leases
Increase Decrease Through At-the-market Value Of Shares
Increase decrease through at-the-market value of shares.
Shares issued pursuant to ATM
Non-current portion
Non-current lease liabilities
Over Next Six Months [Member]
Over next six months.
Classes of financial assets [axis]
Classes of financial assets [axis]
Expected life
Option life, share options granted
Document Fiscal Period Focus
Non-cash changes, Debt forgiven/ Settlement/ Disposal
Increase Decrease Through Debt Forgiven Or Settlement Or Disposal Liabilities Arising From Financing Activities
Increase decrease through debt forgiven or settlement or disposal liabilities arising from financing activities.
Disclosure of detailed information about intangible assets [abstract]
Entity Shell Company
Additions other than through business combinations, property, plant and equipment including right-of-use assets
Additions
Remaining life (year)
Warrants Outstanding Remaining Life
Warrants outstanding remaining life.
Proceeds from issue of convertible debentures
Proceeds
Proceeds from issue of bonds, notes and debentures
Proceeds from debenture
Goodwill
Description of accounting policy for goodwill [text block]
BioStrand Two [Member]
BioStrand.
BioStrand
Net cash flows from (used in) financing activities
Cash flows from (used in) financing activities
Net cash provided by financing activities
Severance (included in salaries)
Key management personnel compensation, post-employment benefits
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Disclosure In Tabular Form Of Nature Of Companies Leases [Line Items]
Disclosure in tabular form of nature of companies leases.
Expiry Date
Options Outstanding Expiry Date
Options outstanding expiry date.
ImmunoPrecise Netherlands B.V.
Immuno Precise Netherlands B V [Member]
ImmunoPrecise Netherlands B.V.
Depreciation, property, plant and equipment including right-of-use assets
Depreciation
Commitments [Line Items]
Commitments.
Foreign exchange
Effect of exchange rate changes on cash and cash equivalents
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Disclosure of reconciliation of liabilities arising from financing activities [line items]
No. of leases with variable payments linked to an index
Number Of Leases With Options To Purchase
Number of leases with options to purchase.
Summary of Differences and Related Tax Effects
Disclosure Of Related Tax Effects Explanatory
The disclosure of related tax effects.
Finance costs
Financing costs
Finance costs
Total cash
Cash
Cash
Number of common shares sold.
Number of common shares sold
Number of common shares sold/issued
Entity Filer Category
Basic earnings (loss) per share from discontinued operations
INCOME PER SHARE FROM DISCONTINUED OPERATIONS - BASIC
Certifications
Certifications
Certifications [Member]
Certifications.
Not Later Than One Year
Not later than one year [member]
2027
Business combinations
Description of accounting policy for business combinations and goodwill [text block]
Period [Axis]
Period.
BioStrand B.V. d/b/a MindWalk [Member]
Biostrand B.V. d/b/a mindwalk.
BioStrand B.V. d/b/a MindWalk
Minimum contingent earnout payment
Minimum Contingent Earnout Payment
Minimum contingent earnout payment.
Segments [domain]
Summary of Temporary Differences to Deferred Income Tax Assets and Liabilities
Disclosure of deferred taxes [text block]
BioKey BV [Member]
Biokey BV.
BioKey BV
Cost of sales
COST OF SALES
Cost of sales
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Management Third Party Engaged [Flag]
Total cash and cash equivalents
Cash
Cash and cash equivalents
Cash - end of the year
Cash - beginning of the year
ASSETS
Assets [abstract]
LEASES
Disclosure of leases [text block]
Option Ten [Member]
Option ten.
Option Expiry Date August 8, 2033
Disclosure of transactions between related parties [abstract]
Transaction costs
Business Combination Transaction Costs
Business combination transaction costs.
Comprehensive income
Comprehensive loss for the year
COMPREHENSIVE LOSS FOR THE YEAR
Lease obligation monthly repayment amount.
Interest and accretion
Lease Obligation Monthly Repayments Amount
Grant awarded
Government grants
Profit (Loss) On Disposal Of Assets
Profit (loss) on disposal of assets.
Loss on disposal of discontinued operations
Impairment of long-lived assets
Description of accounting policy for impairment of assets [text block]
Carrying amount [member]
Carrying amount [member]
Accounts payable and accrued liabilities
Accounts payable and accrued liabilities
Accounts Payable And Accrued Liabilities
Accounts payable and accrued liabilities.
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units [Table]
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units
Term
Useful life measured as period of time, property, plant and equipment
Disclosure Of Financial Instruments [Line Items]
Disclosure of detailed information about financial instruments [line items]
Weighted Average Exercise Price Of Share Options Vested and Outstanding
Weighted average exercise price of share options vested and outstanding.
Weighted average exercise price, Vested and outstanding
Increase (decrease) through net exchange differences, property, plant and equipment including right-of-use assets
Foreign exchange
Summary of Changes in Value of New Debentures
Disclosure Of Changes In Value Of New Debentures Table [Text Block]
Disclosure of changes in value of new debentures.
WIP - Leasehold Improvements
Work In Progress Leasehold Imrpvements [Member]
Work In Progress Leasehold Imrpvements.
Currency
Currency [Axis]
Diluted earnings (loss) per share from continuing operations
LOSS PER SHARE FROM CONTINUING OPERATIONS - DILUTED
Total present value of minimum lease payments
Lease liabilities
Country of Incorporation
Country of incorporation of subsidiary
Acquisition of BioStrand
Additional recognition, goodwill
Acquisition of BioStrand
Cybersecurity Risk Management, Strategy, and Governance [Table]
Cryo Storage Revenue
Cryo Storage [Member]
Cryo storage.
Total intangible assets other than goodwill
Intangible assets
Beginning balance
Ending balance
Intangible assets other than goodwill
Grant and subsidy income
Grant And Subsidy Income
Grant and subsidy income.
Non-current portion
Noncurrent Deferred Cash Payments
Noncurrent deferred cash payments.
Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [line items]
Period of deferred cash payments
Period Of Deferred Cash Payments
Period of deferred cash payments.
Disclosure of allowance for credit losses [text block]
Schedule of Details of Amounts Receivable and Allowances for Credit Losses
Document Shell Company Report
Non capital loss carried forward expiration period
Non Capital Loss Carried Forward Expiration Period
Non capital loss carried forward expiration period.
Prior year tax assessments and adjustments
Prior year tax assessments and adjustments
Prior year tax assessments and adjustments.
Disclosure of non-adjusting events after reporting period [abstract]
Subsidiaries [domain]
Option One [Member]
Option one.
Option Expiry Date January 7, 2027
Goodwill (not deductible for tax purposes)
Goodwill recognised as of acquisition date
Disclosure of non-adjusting events after reporting period [line items]
Employee benefits
Other short-term employee benefits
Other
Other tax effects for reconciliation between accounting profit and tax expense (income)
Profit (loss) before tax
Loss before income taxes
Loss before income taxes including discontinued operations
Equity Interest percentage
Proportion of ownership interest in subsidiary
Disclosure Of Geographical Areas [Line Items]
Disclosure of geographical areas [line items]
Revenues
Total revenue
REVENUE
INCOME PER SHARE FROM DISCONTINUED OPERATIONS - DILUTED
Diluted earnings (loss) per share from discontinued operations
Unpaid commitment related to earnout
Unpaid commitment related to earnout
Unpaid commitment related to earnout.
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Table]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Table]
Disclosure of maturity analysis of finance and office lease payments.
Net cash flows from (used in) operating activities
Net cash used in operating activities
Cash flows from (used in) operating activities
Liabilities
Liabilities
Total liabilities
Liabilities at beginning of period
Liabilities at end of period
Liabilities
Total liabilities
Total deferred income including contract liabilities recognised as of acquisition date
Deferred revenue
Deferred revenue
Deferred income including contract liabilities recognised as of acquisition date
Liquidity Risk
Liquidity risk [member]
Applicable tax rate
Applicable tax rate
Entity Well-known Seasoned Issuer
Reclassified to Fixed Assets
Reclassified to fixed assets.
Reclassified to fixed assets
Goods or services transferred at point in time [member]
Point-in-Time
Impairment loss
Impairment of Intangible assets
Liabilities arising from financing activities [domain]
Classes of current inventories [abstract]
Summary of Options Outstanding
Disclosure of range of exercise prices of outstanding share options [text block]
Disclosure Of Business Combinations [Table]
Disclosure of detailed information about business combination [table]
Impairments and disposals.
Impairments And Disposals
Impairments and disposals
Discontinued operations [member]
Discontinued Operations
Amendment Flag
SHARE CAPITAL
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure Of Property Plant And Equipment [Line Items]
Disclosure of detailed information about property, plant and equipment [line items]
Borrowings by name [domain]
Capital assets net of lease liabilities
Recognized Capital Assets Net of Lease Liabilities
Recognized capital assets net of lease liabilities.
Entity Address, Postal Zip Code
Categories of related parties [domain]
Accounts payable and accrued liabilities assumed
Trade and other payables recognised as of acquisition date
Weighted average life remaining (years), Unvested
Weighted Average Remaining Life Of Unvested Share Options
Weighted average remaining life of unvested share options.
Cybersecurity Risk Role of Management [Text Block]
Restricted cash
Noncurrent Restricted Cash
Noncurrent restricted cash.
Accretion
Adjustments For Accretion Expense
Adjustments for accretion expense.
Fair value
Weighted average fair value at measurement date, share options granted
Net assets included in discontinued operations
Net assets included in discontinued operations.
Net assets included in discontinued operations
Later Than Two Years and Not Later Than Five Years
Later than two years and not later than five years [member]
Public offering price for each common share.
Public Offering Price For Each Common Share
Public offering price for each common share
Entity Address, Address Line One
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Increase (Decrease) Through Divestitures, Liabilities Arising from Financing Activities
Increase (decrease) through divestitures, liabilities arising from financing activities.
Non-cash changes, Europe B.V. Sale
Summary of Amortization of Intangible Assets with Finite Lives
Disclosure Of Amortization Of Intangible Assets With Finite Lives [Text Block]
Disclosure of amortization of intangible assets with finite lives.
Foreign exchange
Foreign Exchange
Foreign exchange.
Stock Options Grant Date [Axis]
Stock options grant date.
Foreign exchange
Payments Proceeds To Right of Use Assets Foreign Exchange Effect
Payments proceeds to right of use assets foreign exchange effect.
Increase Decrease Through At-The-Market Number Of Shares
Increase decrease through at-the-market number of shares.
Shares issued pursuant to ATM, shares
More than 5 years
Later than five years [member]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
INCOME TAXES
Disclosure of income tax [text block]
Document Type
Aggregate principal amount of convertible debentures agreed to sell and issue.
Aggregate Principal Amount of Convertible Debentures Agreed to Sell and Issue
Aggregate principal amount of convertible debentures agreed to sell and issue
Percentage of revenue
Percentage of entity's revenue
Individual assets or cash-generating units [axis]
Net cash flows from (used in) investing activities
Cash flows from (used in) investing activities
Net cash provided by (used in) investing activities
Entity Central Index Key
Terminal growth rates
Growth rate used to extrapolate cash flow projections
Customer list
Customer List
Customer List [Member]
Customer list.
Income Taxes on Earnings Before Income Taxes Above Statutory Rate
Income taxes on earnings before income taxes above statutory rate
Income taxes on earnings before income taxes, at above statutory rate
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Bottom of Range
Bottom of range [member]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Line Items]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Line Items]
Disclosure of maturity analysis of finance and office lease payments.
Deferred payments paid through cash and equity
Deferred Payments Paid Through Cash And Equity
Deferred payments paid through cash and equity.
Continuing and discontinued operations [axis]
Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [abstract]
Intangible assets other than goodwill [member]
Intangible assets other than goodwill [member]
Commitments [Abstract]
Commitments.
USD
United States of America, Dollars
Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [text block]
Summary of Changes in the Value of Property and Equipment and Right-of-use Assets
Geographical areas [axis]
Geographical areas [axis]
Current income taxes
Current tax expense (income)
Other
All Other Countries [Member]
All other countries.
Disclosure of employee benefits expenses [abstract]
Disclosure of employee benefits expenses.
Amounts receivable, gross
Amounts Receivable Gross
Amounts receivable gross.
Major ordinary share transactions [member]
Major Ordinary Share Transactions
Related party transaction, due from (to) related party
Key management personnel compensation
Adjustments For Depreciation And Amortisation Expense From Discontinued Operations
Adjustments for depreciation and amortisation expense from discontinued operations.
Amortization and depreciation
Euro
Euro Member Countries, Euro
Retained earnings [member]
Accumulated Deficit
Tranche Three [Member]
Tranche Three
Document Financial Statement Error Correction [Flag]
Types of risks [domain]
Section 174 - R&D costs
Unrecognized, Research and Development Costs
Unrecognized, research and development costs.
Summary of Non-cash Investing and Financing Transactions
Disclosure Of Non Cash Investing And Financing Transactions Explanatory
Disclosure of non-cash investing and financing transactions.
Disposals From Right Of Use Assets
Disposals from right of use assets.
Disposals
Disclosure Of Geographical Areas [Table]
Disclosure of geographical areas [table]
Shares issued pursuant to conversion of convertible debentures, Number of Shares
Increase Decrease Through Conversion Of Convertible Instruments Number Of Shares
Increase (decrease) through conversion of convertible instruments, number of shares.
Foreign currency exchange rate
Closing foreign exchange rate
Amounts receivable
Amounts Receivable Recognized As Of Acquisition Date
Amounts receivable recognized as of acquisition date.
Unrecognized Deferred Income Tax Effects, Other
Unrecognized deferred income tax effects, other.
Other
U Protein IPA Europe And Bio strand [Member]
U Protein IPA Europe And Bio strand
Disclosure of subsidiaries [abstract]
Related party transactions [abstract]
Current Fiscal Year End Date
Timing of transfer of goods or services [domain]
Inventories [Abstract]
Inventories
Ranges of exercise prices for outstanding share options [axis]
Ranges of exercise prices for outstanding share options [axis]
Less: imputed interest
Imputed Interest On Lease Liabilities
Imputed interest on lease liabilities.
Bio strand [Member]
Bio strand
Corporate
Corporate Segments [Member]
Corporate segments.
Summary of Subsidiaries which are Wholly Owned and Subject to Control
Disclosure of subsidiaries [text block]
Prepaid expenses
Adjustments for decrease (increase) in prepaid expenses
Settlement of convertible debentures
Settlement of convertible debentures
Settlement of convertible debentures.
Deferred Acquisition Payment Investing Activities
Deferred acquisition payment investing activities.
Deferred acquisition payments
Intangible assets material to entity [domain]
EXPENSES
Expenses by nature [abstract]
Entity Address, State or Province
Share issuance costs
Description Of Accounting Policy For Share Issuance Costs Explanatory [Text Block]
Description of accounting policy for share issuance costs explanatory.
Immuno Precise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics [Member]
Immuno precise antibodies (canada) Ltd. d/ba/ mindwalk biologics.
ImmunoPrecise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics
Investments accounted for using equity method [abstract]
Shares issued pursuant to conversion of convertible debentures, shares
Issue Of Convertible Instruments Number Of Shares
Issue of convertible instruments number of shares.
Net cash used in investing activities
Cash flows from (used in) investing activities, discontinued operations
Net cash flows from (used in) investing activities, discontinued operations
Research and development
Description of accounting policy for research and development expense [text block]
Current liabilities
Current liabilities
Current liabilities
Write-downs (reversals of write-downs) of inventories [abstract]
Accumulated Amortization
Accumulated Amortization [Member]
Accumulated amortization.
Automobile
Automobile [Member]
Automobile.
Term
Intellectual property assets useful life
Useful life measured as period of time, intangible assets other than goodwill
Non-adjusting events after reporting period [axis]
Sales agent commissions and other offering expenses
Sales agent commissions and other offering expenses.
Schedule of reconciliation of changes in goodwill
Disclosure of reconciliation of changes in goodwill [text block]
Exchange difference on translating foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Exchange differences on foreign operations
Accrued liabilities related parties current
Accrued Liabilities Related Parties Current
Accrued liabilities related parties current.
Foreign exchange
Increase (decrease) through net exchange differences, goodwill
Amounts receivable, net
Current Amounts Receivable
Current amounts receivable.
Unrealized foreign exchange gain (loss)
Unrealized foreign exchange gain (loss).
Unrealized foreign exchange (loss) gain
Accounts payable due to related parties
Payables to related parties
Non-cash changes, Discontinued Operations
Increase Decrease Through Financing Discontinued Operations Liabilities Arising From Financing Activities
Increase decrease through financing discontinued operations liabilities arising from financing activities.
IPA Europe
I P A Europe [Member]
IPA Europe.
Payroll taxes
Payroll taxes
Payroll taxes.
Lab Equipment
Lab Equipment [Member]
Lab equipment.
Variable lease payments
Expense relating to variable lease payments not included in measurement of lease liabilities
Cash-generating units [domain]
Summary of Classification and Measurement of Financial Assets and Liabilities
Disclosure of detailed information about financial instruments [text block]
On and after November 1, 2024
On and after November 1, 2024 member.
On and After November One, Two Thousand Twenty Four [Member]
Exercise price
Exercise price of outstanding share options
Government assistance
Description Of Accounting Policy For Government Assistance [Text Block]
Description of accounting policy for government assistance.
Summary of Changes in Value of Deferred Payments
Summary of Changes in Value of Subsequent Payments
Disclosure Of Changes In Value Of Deferred Payment Explanatory
Disclosure of changes in value of deferred payment.
Accumulated Other Comprehensive (Loss) Income
Accumulated other comprehensive income [member]
Weighted average exercise price, Forfeited
Weighted average exercise price of share options forfeited in share-based payment arrangement
BELGIUM
Belgium
Share-based payments
Description of accounting policy for share-based payment transactions [text block]
At The Market Equity Offering Facility [Member]
At the market equity offering facility.
At The Market Equity Offering Facility
Option Twelve [Member]
Option twelve.
Option Expiry Date February 19, 2034
Proprietary processes (not deductible for tax purposes)
Proprietary Processes Intangible Assets Recognised As Of Acquisition Date
Proprietary processes intangible assets recognised as of acquisition date.
Statistical Measurement
Range [axis]
Tax benefits not recognized
Tax Effect To Tax Benefits Not Recognized
Tax effect to tax benefits not recognized.
Disclosure of operating segments [abstract]
Number of options, Exercised
Number of options, Exercised
Number of share options exercised in share-based payment arrangement
Commitments [Table]
Commitments.
Investing activities:
Cash flows from (used in) investing activities [abstract]
Deferred acquisition payment
Deferred acquisition payment.
Deferred acquisition payments
Segments [axis]
Segments [axis]
Victoria One [Member]
Victoria One.
Victoria
Total minimum lease payments
Future Minimum Finance And Office Lease Payments
Future minimum finance and office lease payments.
Weighted average exercise price, Exercisable
Weighted average exercise price of share options exercisable in share-based payment arrangement
Deferred acquisition payments
Deferred acquisition payments
Beginning balance
Ending balance
Deferred Acquisition Payments
Deferred acquisition payments.
Percentage of purchase price to aggregate principal amount
Percentage of purchase price to aggregate principal amount.
Percentage of Purchase Price to Aggregate Principal Amount
Income Tax Expense Including Discontinued Operations
Income tax expense including discontinued operations.
Income taxes including discontinued operations
Disclosure of terms and conditions of share-based payment arrangement [table]
Number of common shares issued
Number of instruments or interests issued or issuable
Contributed Surplus
Additional paid-in capital [member]
BioStrand B.V.
BioStrand B.V. [Member]
Biostrand b.v.
Summary of disclosure in tabular form of nature of companies leases
Disclosure In Tabular Form Of Nature Of Companies Leases
Disclosure in tabular form of nature of companies leases.
Schedule of Nature of Company's Leases Type of Right-of-Use Asset
Classes of intangible assets other than goodwill [domain]
Internally generated development costs
Internally Generated Development Costs
Internally Generated Development Costs [Member]
Internally generated development costs.
Disclosure of property, plant and equipment [text block]
PROPERTY AND EQUIPMENT (INCLUDING RIGHT OF USE ASSETS)
Disclosure of disaggregation of revenue from contracts with customers [text block]
Summary of Revenue Recognized Over Time Versus at Point in Time
Capital Management [Abstract]
Capital management.
Inventory write-down
Inventory write-offs
Audited Annual Financial Statements
Exercisable price/option
Exercise price, share options granted
Gross proceeds from sale of common shares
Gross proceeds from sale of common shares.
Deffered Tax liability
Deffered tax liability.
Defered tax liability
Auditor Firm ID
Products and services [axis]
Products and services [axis]
Project Revenue
Project Revenue [Member]
Project revenue.
Leases
Leases recognised as of acquisition date
Leases recognised as of acquisition date.
Leases
Summary of Geographical Segments
Disclosure of geographical areas [text block]
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Wages, salaries
Salaries and benefits
Wages and salaries
Individual assets or cash-generating units [domain]
INVESTMENT
Disclosure of investments accounted for using equity method [text block]
Disclosure of details of Finder's warrants outstanding.
Details of Finder's Warrants Outstanding
Disclosure Of Details Of Finders Warrants Outstanding Explanatory
Australia
Australia [Member]
AUSTRALIA
Revenue from contracts with customers
Revenue
Total liabilities and shareholders' equity
Equity and liabilities
Additions
Additions to right-of-use assets
Disclosure of reconciliation of changes in property, plant and equipment, including right-of-use assets [table]
Range One
Range One [Member]
Range one.
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Types of antidilutive instruments [domain]
Revenue recognition
Description of accounting policy for recognition of revenue [text block]
Disclosure of analysis of single amount of discontinued operations [table]
Types of risks [axis]
Types of risks [axis]
No. of leases with termination options
Number Of Leases With Termination Options
Number of leases with termination options.
Basis
Amortisation method, intangible assets other than goodwill
Document Information [Line Items]
Stock Options Grant Date [Member]
Stock options grant date.
Adjustments for share-based payments
Share-based expense
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
Loss on disposal of subsidiary
Acquisition Of Building And Equipment By Lease
Acquisition of building and equipment by lease.
Acquisition of building and equipment by lease
Disclosure of quantitative information about right-of-use assets [abstract]
Disclosure of information for cash-generating units [table]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Profit (loss) from discontinued operations
NET INCOME FROM DISCONTINUED OPERATIONS
NET INCOME FROM DISCONTINUED OPERATIONS
Disclosure In Tabular Form Of Nature Of Companies Leases [Table]
Disclosure in tabular form of nature of companies leases.
Option Thirteen [Member]
Option thirteen.
Option Expiry Date August 2, 2034
Option 13
Non-cash changes, Acquisition
Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities
Sales and income taxes payable and receivable
Adjustments For Increase Decrease In Taxes Payable And Receivable
Adjustments for increase (decrease) in taxes payable and receivable.
Earnings (loss) per share
Description of accounting policy for earnings per share [text block]
SUPPLEMENTAL CASH FLOW INFORMATION
Disclosure of cash flow statement [text block]
Document Registration Statement
EMPLOYEE REMUNERATION
Disclosure of employee benefits [text block]
Goodwill
Goodwill
Goodwill
Goodwill
Capital requirements [axis]
Capital requirements [axis]
Disclosure of initial application of standards or interpretations [abstract]
Less: Current portion
Current lease liabilities
Leases
Leases
Description of accounting policy for leases [text block]
Convertible Debentures [Line Items]
Convertible Debentures [Line Items]
Convertible debentures.
Percentage of interest in investment
Percentage Of Interest In Investment
Percentage of interest in investment.
Classes of share capital [domain]
Business Contact [Member]
Adoption of New Accounting Standards
Disclosure of initial application of standards or interpretations [text block]
Interest and other income (expense)
Interest and other income (expense).
Interest and other (expense) income
Percentage of shares to be released to vendors
Percentage Of Shares To Be Released To Vendors
Percentage Of Shares To Be Released To Vendors
Disclosure of detailed information about intangible assets [line items]
Disclosure Of Financial Instruments [Table]
Disclosure of detailed information about financial instruments [table]
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Share-based payments
Expense from share-based payment transactions with employees
Share-based expense
Income before other income (expenses) and income taxes
Income before other income (expenses) and income taxes.
Income before other income (expenses) and income taxes
Netherlands
NETHERLANDS
VLAIO [Member]
VLAIO
United States of America
UNITED STATES
Classes of share capital [axis]
Classes of share capital [axis]
Types of share-based payment arrangements [domain]
Accounts Payable and Accrued Liabilities
Accounts Payables And Accrued Liabilities [Member]
Accounts payables and accrued liabilities.
Share capital
Description of accounting policy for issued capital [text block]
Presentation of Leases for Lessee [Table]
Presentation of leases for lessee.
Work in process
Current work in progress
Percentage of contingent earnout payment based on EBITDA
Percentage Of Contingent Earnout Payment Based On EBITDA
Percentage of contingent earnout payment based on EBITDA.
Number Of Shares Exercise By Underwriter Of Over Allotment Option
Number of shares exercise by underwriter of over allotment option
Number of shares exercise by underwriter of over allotment option
Computer Software
Computer software [member]
Discount rates
Discount rate applied to cash flow projections
BioStrand Five [Member]
BioStrand five.
BioStrand
Expired, Weighted average exercise price
Weighted Average Exercise Price Warrants Expired
Weighted average exercise price warrants expired
Option Eleven [Member]
Option eleven.
Option Expiry Date November 13, 2033
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cash Flows
Increase (decrease) through financing cash flows, liabilities arising from financing activities
Weighted average share price
Weighted average share price
Market price
Utrecht
Untrecht [Member]
Agreement [Axis]
Agreement
Director compensation (included in salaries)
Key Management Personnel Compensation Director Compensation Included In Salaries
Key management personnel compensation Director compensation included in salaries.
Term
Description of useful life, property, plant and equipment
SUBSEQUENT EVENTS
Disclosure of events after reporting period [text block]
Number of options, Exercisable
Number of share options exercisable in share-based payment arrangement
Securities purchase agreement with YA II PN, Ltd member.
Securities Purchase Agreement with YA II PN, Ltd [Member]
Securities Purchase Agreement with YA II PN, Ltd
BioStrand Three [Member]
BioStrand three.
BioStrand
Talem Therapeutics LLC ("Talem")
Talem Therapeutics L L C Talem [Member]
Talem Therapeutics LLC ("Talem").
Critical Accounting Estimates And Judgments [Abstract]
Critical accounting estimates and judgments.
Disclosure of geographical areas [abstract]
Options outstanding
Number of options, Outstanding, Beginning balance
Number of options, Outstanding
Number of share options outstanding in share-based payment arrangement
Entity Address, City or Town
Later than three years and not later than four years [member]
2030
Continuing operations, unless line item indicates otherwise [member]
Total non-current assets
Non-current assets
Security Exchange Name
Agreement [Member]
Agreement
Europe
Europe [Member]
Increase Decrease Through Sale of Subsidiary Liabilities Arising from Financing Activities
Increase decrease through sale of subsidiary liabilities arising from financing activities.
Non-cash changes, Europe B.V Sale
Contact Personnel Name
Amounts receivable
Adjustments for decrease (increase) in trade accounts receivable
Exercise price $
Warrants Outstanding Exercise Price
Warrants outstanding exercise price.
Cash paid at the time or acquisition
Cash paid at the time or acquisition
Cash paid at the time or acquisition.
MindWalk B.V. [Member]
MindWalk B.V.
MindWalk B.V.
Ninety Days [Member]
Ninety days.
Disclosure Of Classes Of Share Capital [Line Items]
Disclosure of classes of share capital [line items]
Deferred tax liabilities
Deferred income tax liability
Deferred acquisition payments
Current Deferred Acquisition Payments
Current deferred acquisition payments.
Less: unrecognized deffered income tax asset
Unrecognized Deferred Income Tax Asset
Unrecognized deferred income tax asset.
Statement of changes in equity [abstract]
Acquisition of building and equipment by lease
Contractual commitments for acquisition of property, plant and equipment
Profit (loss)
Net losses
Operating losses
Net loss for the year including discontinued operations
NET LOSS FOR THE YEAR
Net income (loss) including discontinued operations
Non Capital Losses Carried Forward
Non capital losses carried forward.
Non-capital losses carried forward (expire from 2027 to 2040)
Cash on hand
Document Period End Date
SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE
Disclosure of entity's operating segments [text block]
Disclosure of objectives, policies and processes for managing capital [line items]
ICFR Auditor Attestation Flag
Categories of related parties [axis]
Categories of related parties [axis]
Option Two [Member]
Option two.
Option Expiry Date January 13, 2027
Warrants outstanding
Balance, Number of warrants
Balance, Number of warrants
Number Of Warrants Outstanding
Number of warrants outstanding.
Disclosure of non-adjusting events after reporting period [table]
Stock options granted
Number of instruments granted in share-based payment arrangement
Beginning balance
Ending balance
Right-of-use assets
Awarded to
Share Based Payment Grantee Description
Share based payment grantee description.
Number of right of use assets leased
Number Of Right Of Use Assets Leased
Number of right of use assets leased.
Leases
Noncurrent Leases
Noncurrent leases.
Customer-related intangible assets [member]
Customer List
Total issued capital
Share capital
Issued capital
Option Nine [Member]
Option Nine.
Option Expiry Date January 19, 2034
Option Expiry Date June 11, 2033
Tax income (expense)
Income taxes
Tax expense (income)
Income taxes
Term for calculating profit marging for cash generating units
Term Of Calculating Profit For Cash Generating Units
Term Of Calculating Profit For Cash Generating Units
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")
Immuno Precise Antibodies U S A Ltd I P A U S A [Member]
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA").
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Total expenses
Expenses, by nature
Immuno Precise Antibodies N D Ltd [Member]
ImmunoPrecise Antibodies (N.D.) Ltd.
ImmunoPrecise Antibodies (N.D.) LTD
Proceeds from sale of common shares.
Proceeds from Sale of Common Shares
Proceeds from sale of common shares
Amortisation, intangible assets other than goodwill
Amortization on the intangible assets
Amortisation, intangible assets other than goodwill
Amortization of intangible assets
Unvested
Number Of Unvested Share Options
Number of unvested share options.
Products and services [domain]
Timing of transfer of goods or services [axis]
Classes of financial assets [domain]
Proceeds from grants
Proceeds from government grants, classified as investing activities
Dividend yield
Expected dividend as percentage, share options granted
Ranges of exercise prices for outstanding share options [domain]
All Currencies
All Currencies [Domain]
Accounts payable and accrued liabilities
Adjustments for increase (decrease) in trade and other payables
Weighted average share price, share options granted
Share price on grant date
Profit (loss) from continuing operations
Loss before income taxes
NET LOSS FROM CONTINUING OPERATIONS
Loss from continuing operations
Flemish Regional Government IN Belgium [Member]
Flemish Regional Government IN Belgium
Entity File Number
Remaining life (year)
Remaining Life Of Outstanding Share Options
Remaining life of outstanding share options.
Impairment of long-lived assets, description
Description of nature of individual asset
Recognized Inventory And Intangible Assets
Recognized Inventory And Intangible Assets
Inventory and Intangible assets
Inventory and Intangible assets
Deposit on equipment
Deposit On Equipment
Deposit on equipment.
Cover [Abstract]
Oss
Oss [Member]
Oss Member
YA II PN, Ltd [Member]
YA II PN, Ltd.
YA II PN, Ltd.
Disclosure of quantitative information about right-of-use assets [line items]
Currency Risk
Currency risk [member]
Supplies and parts
Current production supplies
Tranche One [Member]
Tranche One
Trance One
RELATED PARTY TRANSACTIONS
Disclosure of related party [text block]
Current liabilities
Current liabilities [abstract]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Deferred revenue
Current Deferred Revenue
Current deferred revenue.
Description of vesting requirements for share-based payment arrangement
Vesting period
Description of vesting requirements for share-based payment arrangement
Current tax assets, current
Tax receivable
Asset impairment
Impairment loss recognised in profit or loss, goodwill
Impairment loss
Impairment of goodwill
Impairment of Goodwill
Asset impairment
Schedule of In Tabular Form Of Allocating Goodwill To Cash Generating Units
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units [Table Text Block]
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units
Deferred cash payment
Deferred acquisition payment
Deferred Cash Payment
Deferred cash payment.
Summary of Changes in Stock Option
Disclosure of number and weighted average exercise prices of share options [text block]
Total income taxes paid (refund)
Cash paid for income tax
Income taxes paid (refund)
Range of remaining term
Remaining Lease Term
Remaining lease term.
Computer Hardware
Computer Hardware [Member]
Computer Hardware.
Beginning balance, shares
Ending balance, shares
Number of shares outstanding
Total net assets acquired and liabilities assumed
Identifiable Assets Acquired Liabilities Assumed Net
The amount recognised as of the acquisition date for net identifiable
assets acquired or liabilities assumed in a business combination.
Goods or services transferred over time [member]
Over Time
Inventory
Adjustments for decrease (increase) in inventories
Disposal of subsidiary
Disposal of Subsidiary
Disposal of subsidiary.
Debt conversion principal debt amount
Debt Conversion Principal Debt Amount
Debt conversion principal debt amount.
Disclosure of terms and conditions of share-based payment arrangement [line items]
Goodwill
Disclosure of goodwill [text block]
Impairment loss
Tax effect of impairment of goodwill
Disclosure of reconciliation of changes in goodwill [table]
Capital requirements [domain]
Later Than One Year and Not Later Than Two Years
Later than one year and not later than two years [member]
2028
Cash paid for interest
Cash Paid For Interest
Cash paid for interest.
Net foreign exchange gain (loss)
Foreign exchange
Foreign exchange gain (loss)
Cybersecurity Risk Management Processes Integrated [Flag]
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase (decrease) in cash during the year
Risk- free rate
Risk free interest rate
Risk free interest rate, share options granted
Document Transition Report
Property, plant and equipment including right-of-use assets
Beginning balance
Ending balance
Financial instruments
Description of accounting policy for financial instruments [text block]
Profit or loss [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Option Three [Member]
Option Three.
Option Expiry Date May 9, 2026
Option Expiry Date May 15, 2027
Statement of financial position [abstract]
Gross profit
GROSS PROFIT
Gross profit
Deferred tax expense (income)
Deferred income taxes
Option Five [Member]
Option five.
Option Expiry Date February 19, 2028
Summary of Allocated Purchase Price
Disclosure of detailed information about business combination [text block]
Types of investment property [domain]
Vested
Number Of Vested Share Options
Number of vested share options.
Disclosure Of Investment [Abstract]
Disclosure of investment.
Current assets
Current assets [abstract]
Classes of assets [domain]
Weighted average exercise price, Granted
Weighted average exercise price of share options granted in share-based payment arrangement
Convertible Debentures [Abstract]
Convertible debentures.
Components of equity [axis]
Components of equity [axis]
Types of antidilutive instruments [axis]
Items not affecting cash
Cash flows from (used in) operations before changes in working capital
Period of deferred acquisition payments
Period Of Deferred Acquisition Payments
Period of deferred acquisition payments.
Cybersecurity Risk Management Processes Integrated [Text Block]
Accumulated Depreciation
Accumulated Depreciation Amount [Member]
Accumulated depreciation amount [Member].
Disclosure Of Nature Of Operations And Going Concern [Text Block]
Disclosure of nature of operations and going concern.
Nature of Operations and Going Concern
BioClue BV [Member]
Bioclue BV.
BioClue BV
Business combinations [domain]
Increase Decrease Through Restricted Stock Unit Number of Shares
Increase decrease through restricted stock unit number of shares.
Shares issued for vesting on restricted share units
Convertible debentures
Beginning balance
Ending balance
Convertible Debentures
Convertible debentures.
Deferred acquisition payments discount rate
Deferred Acquisition Payments Discount Rate
Deferred acquisition payments discount rate.
CONVERTIBLE DEBENTURES
Convertible Debentures Explanatory [Text Block]
Convertible debentures.
Leases
Lease liabilities [member]
Amortization and depreciation
Adjustments for depreciation and amortisation expense
Repayment
Acquisition Cost Repayment
Acquisition cost repayment.
Description of accounting policy for property, plant and equipment [text block]
Property and Equipment
Business combinations [axis]
Business combinations [axis]
Basis Of Accounting [Abstract]
Basis of accounting.
Disclosure of analysis of single amount of discontinued operations [text block]
Summary of Discontinued Operations
Basic earnings (loss) per share from continuing operations
LOSS PER SHARE FROM CONTINUING OPERATIONS - BASIC
Unbilled revenue
Adjustments For Decrease Increase In Unbilled Revenue
Adjustments for decrease (increase) in unbilled revenue.
Maturity [domain]
Beginning balance
Ending balance
Liabilities arising from financing activities
Inventories
Inventory
Current inventories
Allowance for credit losses.
Allowance For Credit Losses
Allowance for credit losses
Cash flows from (used in) financing activities, discontinued operations
Net cash flows from (used in) financing activities, discontinued operations
Net cash used in financing activities
Tax Effect of Expense Non-Deductible (Income) Expenses
Tax effect of expense non-deductible (income) expenses.
Nondeductible (income) expenses
Document Fiscal Year Focus
Biostrand B V [Member]
Biostrand B V.
Biostrand BV
Common Shares
Potential ordinary share transactions [member]
Capital Management
Capital Management [Member]
Capital management.
Common Shares
Ordinary shares [member]
Maturity [axis]
Maturity [axis]
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
Weighted average number of ordinary shares used in calculating basic earnings per share
Geographical areas [domain]
Basis
Depreciation method, property, plant and equipment
Unbilled revenue
Unbilled Revenue Recognized As Of Acquisition Date
Unbilled revenue recognized as of acquisition date.
Disposals, property, plant and equipment including right-of-use assets
Disposals
Option Seven [Member]
Option seven.
Option Expiry Date January 4, 2033
Subsidiaries [axis]
Subsidiaries [axis]
Expense relating to leases of low-value assets for which recognition exemption has been used
Leases of low value assets
Utrecht [Member]
Utrecht
Equipment and right-of-use assets
Equipment And Right Of Use Assets
Equipment and right-of-use assets.
Cost
Gross carrying amount [member]
Proceeds on share issuance, net of transaction costs
Proceeds from issuing shares
Canada
CANADA
North America
North America [Member]
Fair value of consideration
Business acquisition, purchase consideration
Consideration transferred, acquisition-date fair value
Current tax liabilities, current
Tax payable
Income taxes payable
Weighted average exercise price, Exercised
Weighted average exercise price of share options exercised in share-based payment arrangement
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units [Line Items]
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units
Accretion
Accretion
Accretion.
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS
Disclosure Of Critical Accounting Estimates And Judgments [Text Block]
Disclosure of critical accounting estimates and judgments.
Net cash used in operating activities
Cash flows from (used in) operating activities, discontinued operations
Net cash flows from (used in) operating activities, discontinued operations
Unrecognized deferred income tax liabilities
Unrecognized Deferred Income tax Liabilities
Unrecognized Deferred Income tax Liabilities
Unrecognized deferred income tax liabilities
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Items that will be subsequently reclassified to statements of loss
Disclosure Of Significant Investments In Subsidiaries [Table]
Disclosure of subsidiaries [table]
Common shares of the Company
Fair value of common shares issued
Equity interests of acquirer
Number of options, Forfeited
Number of share options forfeited in share-based payment arrangement
LIABILITIES
Liabilities [abstract]
Financing activities:
Cash flows from (used in) financing activities [abstract]
Financial liabilities, Classification and measurement IFRS 9
Financial liabilities, measurement category immediately after initial application of IFRS 9
Oss The Netherlands [Member]
INTANGIBLE ASSETS
Disclosure of intangible assets [text block]
Income taxes
Description of accounting policy for income tax [text block]
Range [domain]
Weighted average exercise price, Unvested
Weighted Average Exercise Price Of Share Options Unvested In Share Based Payment Arrangement
Weighted average exercise price of share options unvested in share-based payment arrangement.
Statement Of Changes In Equity [Line Items]
Statement of changes in equity [line items]
Loss Before Other Income Expenses And Income Taxes
Loss before other income (expenses) and income taxes.
Loss before other income (expenses) and income taxes
Recognized deferred income tax liabilities
Recognized deferred income tax liabilities
Recognized deferred income tax liabilities
Recognized deferred income tax liabilities, Total
Total property, plant and equipment
Property and equipment
Beginning balance
Ending balance
Property, plant and equipment
Title of 12(b) Security
Number of options, Granted
Stock options granted
Number of share options granted in share-based payment arrangement
Revenue from customers accounted for more than 10% of revenue
Revenue from Customers Accounted for More Than 10 Percentage of Revenue
Revenue from customers accounted for more than 10 percentage of revenue.
Proceeds on disposal of subsidiary
Proceeds on disposal of subsidiary.
Proceeds on disposal of subsidiary
Summary of Classification and Measurement of Financial Assets and Liabilities
Disclosure Of Financial Assets And Liabilities At Date Of Initial Application Of IFRS 9 Explanatory [Text Block]
Disclosure of financial assets and liabilities at date of initial application of IFRS 9 explanatory.
OTHER INCOME (EXPENSES)
Other Income Expenses [Abstract]
Other income (expenses).
Estimated SR&ED ITC
Estimated SR&ED ITC
Tax Effect of Estimated SR and ED Income Tax Credit
Tax effect of estimated SR and ED income tax credit.
Document Information [Table]
Types of investment property [axis]
Options with 5 Years Period
Options With Five Years Period [Member]
Options with five years period.
No. of leases with options to purchase
Number Of Leases With Variable Payments Linked To Index
Number of leases with variable payments linked to index.
Later than two years and not later than three years [member]
2029
Summary of Detailed Information About Inventories
DisclosureOfDetailedInformationAboutInventoriesExplanatory [Text Block]
Disclosure of detailed information about inventories explanatory.
Furniture and Equipment
Fixtures and fittings [member]
Impairment loss recognised in profit or loss, intangible assets other than goodwill
Impairment loss recognised in profit or loss, intangible assets other than goodwill
Impairment of intangible assets charge
Impairment of Intangible assets
Decrease through classified as held for sale, property, plant and equipment including right-of-use assets
Discontinued Operations
Non-cash changes, Accretion
Increase Decrease Through Accretion Liabilities Arising From Financing Activities
Increase decrease through accretion liabilities arising from financing activities.
Tranche [Axis]
Tranche
Disclosure of detailed information about financial instruments [abstract]
Disclosure of objectives, policies and processes for managing capital [table]
Summary of Changes in Liabilities Arose From Financing Activities
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Trading Symbol
BioStrand Four [Member]
BioStrand four.
BioStrand
BASIS OF PRESENTATION
Disclosure of basis of preparation of financial statements [text block]
Number of option, Expired
Number of share options expired in share-based payment arrangement
Summary of Revenues Allocated According to Revenue Types
Disclosure of products and services [text block]
Disclosure of critical accounting estimates and judgments.
Disclosure Of Critical Accounting Estimates And Judgments [Line Items]
Disclosure Of Critical Accounting Estimates And Judgments [Line Items]
Measurement of the lease liability
Expenses Relating To Payment Not Included In The Measurement Of Lease Liability
Expenses relating to payment not included in the measurement of lease liability.
Building
Buildings [member]
Other tax pools
Recognized Other Tax Pools
Recognized Other Tax Pools
Depreciation
Depreciation, right-of-use assets
Lab and office facilities
Lab And Office Facilities [Member]
Lab and office facilities.
Initial term of lease
Initial term of lease
Initial term of lease.
Entity Ex Transition Period
Disclosure Of Classes Of Share Capital [Table]
Disclosure of classes of share capital [table]
Weighted average exercise price of share options exercisable in share based payment arrangements.
Weighted average exercise price of share options exercisable in share based payment arrangements
Weighted average life remaining (years), Exercisable
Accumulated Depreciation
Accumulated depreciation and amortisation [member]
Option Four And Five [Member]
Option Four And Five.
Option 4 and 5
Address Type [Domain]
Restricted share units [member]
Restricted Stock Units
Document Annual Report
Security Deposit On Leases.
Security Deposit On Leases
Security depost on leases
Product Sales Revenue
Product Sales [Member]
Product sales.
Increase (decrease) through disposal of subsidiary, equity
Reclassification to profit or loss on disposal of subsidiary
Equity [abstract]
SHAREHOLDERS' EQUITY
Financial Assets, Cash and Restricted Cash [Member]
Financial assets, cash and restricted cash.
Cash and Restricted Cash
Borrowings by name [axis]
Borrowings by name [axis]
Cash
Cash and cash equivalents recognised as of acquisition date
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Disclosure Of Business Combinations [Line Items]
Disclosure of detailed information about business combination [line items]
Disclosure Of Intangible Assets [Table]
Disclosure of detailed information about intangible assets [table]
Document Accounting Standard
COMMITMENTS
Disclosure of commitments [text block]
Total assets
Assets at beginning of period
Assets at end of period
Assets
Number of options, Unvested
Number Of Share Options Unvested In Share Based Payment Arrangement
Number of share options unvested in share-based payment arrangement
Foreign exchange
Adjustments for unrealised foreign exchange losses (gains)
Entity Addresses, Address Type [Axis]
Cash is comprised of:
Cash and cash equivalents [abstract]
Salaries and other short-term benefits
Key Management Personnel Compensation Salaries And Other Short Term Benefits
Key management personnel compensation salaries and other short-term benefits.
Discontinued operations intangible assets other than goodwill
Discontinued operations intangible assets other than goodwill.
Discontinued operations
Intellectual property (not deductible for tax purposes)
Identifiable intangible assets recognised as of acquisition date
Schedule of Schedule of Compensation For Key Management
Disclosure of transactions between related parties [text block]
Contributed surplus
Contributed Surplus
Contributed surplus.
Total trade and other current receivables
Amounts receivable
Trade and other current receivables
Components of equity [domain]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
A II PN, Ltd.
A II PN, Ltd [Member]
A II PN, Ltd
Balance, Weighted average exercise price
Balance, Weighted average exercise price
Weighted Average Exercise Price Warrants Outstanding
Weighted average exercise price warrants outstanding.
FINANCIAL INSTRUMENTS
Disclosure of financial instruments [text block]
Revenue from contracts with customers timing description.
Revenue From Contracts With Customers Timing Description
Contract revenue timing description
Other income (expenses)
Other operating income (expense)
Weighted average exercise price outstanding, Beginning balance
Weighted average exercise price outstanding, Ending balance
Weighted average exercise price of share options outstanding in share-based payment arrangement
Contact Personnel Email Address
Cash
Cash transferred
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Disclosure Of Detailed Information About Employee Wages Salaries And Benefits Explanatory
Disclosure of detailed information about employee wages, salaries and benefits.
Summary of Expenses Recognized for Employee Wages, Salaries and Benefits
Unbilled revenue
Current Unbilled Revenue
Current unbilled revenue.
Disclosure of quantitative information about right-of-use assets [table]
Adjustments for gains (losses) on fair value adjustment, investment property
Gain on investment
Interest, accretion and other income
Interest, accretion and other income
Interest, accretion and other income
Allowances For Doubtful Accounts [Abstract]
Allowances For Doubtful Accounts.
Deferred Acquisition Payments
Deferred Acquisition Payments [Member]
Deferred acquisition payments.
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Disclosure of reconciliation of liabilities arising from financing activities [table]
Total adjustments for increase (decrease) in deferred income including contract liabilities
Deferred revenue
Adjustments for increase (decrease) in deferred income including contract liabilities
Accretion
Accretion expense
Deferred Payments Accretion Expense
Deferred payments accretion expense.
Weighted average exercise price, Expired
Weighted average exercise price of share options expired in share-based payment arrangement
BioStrand
Biostrand
BioStrand [Member]
BioStrand
Entity Registrant Name
Three August Twenty Twenty Four [Member]
Three august twenty twenty four.
August 3, 2024
Entity Voluntary Filers
Schedule of Contractual Cash Flow Requirements
Disclosure of financial liabilities [text block]
Statement Of Changes In Equity [Table]
Statement of changes in equity [table]
Net Book Value
Net Book Value [Member]
Net Book Value
Convertible Debentures [Table]
Convertible Debentures [Table]
Convertible debentures.
No. of leases with extension options
Number Of Leases With Extension Options
Number of leases with extension options.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Annual Information Form
Disclosure Of Significant Accounting Policies [Abstract]
Disclosure of significant accounting policies.
Victoria.
Victoria [Member]
Victoria
Officers and employee
Officers And Employees [Member]
Officers and employees.
Name of Subsidiary
Name of subsidiary
Goodwill Including Preliminary Value
Goodwill Including Preliminary Value
Goodwill Including Preliminary Value
Entity Common Stock, Shares Outstanding
Equity
Beginning balance
Ending balance
Equity
Total shareholders' equity
Shareholders Equity
Cash flows from continuing and discontinued operations [abstract]
Cash from discontinued operations:
Classes of property, plant and equipment [domain]
Tax rate difference by jurisdiction
Tax effect from change in tax rate
Schedule of Future Minimum Lease Payments Related to Equipment under Finance Lease and Office Lease Obligation
Disclosure Of Detailed Information About Maturity Analysis Of Finance Lease And Office Lease Explanatory
Disclosure of detailed information about maturity analysis of finance lease and office lease.
Number of Share Options Vested and Outstanding
Number of share options vested and outstanding.
GRANT AND SUBSIDY INCOME
Disclosure of government grants [text block]
Proprietary processes
Proprietary Processes
Proprietary Processes [Member]
Proprietary processes.
Option Seven To Twelve [Member]
Option seven to twelve.
Option 7 to 12
Option Four [Member]
Option four.
Option Expiry Date February 19, 2027
Grant And Subsidy Income [Abstract]
Grant and subsidy income.
Office and general
General and administrative expense
General and administrative
Accumulated deficit
Accumulated deficit
Retained earnings
Deferred tax liabilities recognised as of acquisition date
Deferred income tax liability
Intangible assets material to entity [axis]
Credit Facility
Credit Facility
Credit facility.
Summary of Stock Option Awards
Disclosure of terms and conditions of share-based payment arrangement [text block]
Tranche [Member]
Tranche
Computer Hardware
Computer equipment [member]
Lease Agreement
Lease Agreement [Member]
Lease agreement.
Disclosure Of Property Plant And Equipment [Table]
Disclosure of detailed information about property, plant and equipment [table]
Convertible Debentures
Convertible Debentures [Member]
Convertible debentures.
Changes in working capital related to operations:
Changes In Non Cash Working Capital Related To Operations
Changes in non-cash working capital related to operations.
City Area Code
Disclosure of reconciliation of changes in goodwill [line items]
Disclosure Of Income Taxes [Line Items]
Disclosure Of Income Taxes [Line Items]
Disclosure of income taxes.
Intellectual property
Intellectual Properties
Intellectual Properties [Member]
Intellectual properties.
Auditor Name
Sales and marketing
Sales and marketing expense
Tranche Two [Member]
Tranche Two
Trance Two
Schedule of information for cash-generating units
Disclosure of information for cash-generating units [text block]
Cash-generating units [axis]
Weighted average
Weighted average [member]
Escrow Agreement [Member]
Escrow Agreement
Grant date
Date of grant of share-based payment arrangement
Purchase of property, plant and equipment
Purchase of equipment
Purchase of property, plant and equipment, classified as investing activities
Research and development
Research and development expense
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of lease payments not recognized as liability.
Disclosure Of Lease Payments Not Recognized As Liability
Schedule of Lease Payments Not Recognized Liability
Disclosure Of Critical Accounting Estimates And Judgments [Table]
Disclosure Of Critical Accounting Estimates And Judgments [Table]
Disclosure Of critical accounting estimates and judgments.
Statement of cash flows [abstract]
Disclosure Of Nature Of Operations And Going Concern [Abstract]
Disclosure of nature of operations and going concern.
Functional Currency
Description of functional currency
Amounts receivable, net
Amounts Receivable Net
Amounts Receivable Net.
Restricted cash
Restricted cash and cash equivalents
INVENTORIES
Disclosure of inventories [text block]
Disclosure Of Income Taxes [Abstract]
Disclosure of income taxes.
Key management personnel compensation, share-based payment
Share-based expense expense
Classes of assets [axis]
Classes of assets [axis]
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")
Immuno Precise Antibodies Europe B V I P A Europe Formerly Modi Quest Research B V [Member]
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe", formerly ModiQuest Research B.V.
Non-adjusting events after reporting period [domain]
Operating activities:
Cash flows from (used in) operating activities [abstract]
Leases
Current Leases
Current leases.
Expected volatility
Expected volatility, share options granted
Entity Address, Country
Inventory
Description of accounting policy for measuring inventories [text block]
Leasehold Improvements
Leasehold improvements [member]
Capital losses carried forward
Capital Loss Carried Forward
Capital loss carried forward.
Presentation of Leases for Lessee [Line Items]
Presentation of leases for lessee.
Summary of Amortization for intangible assets with finite lives is provided over the following terms
Disclosure of detailed information about intangible assets [text block]
Antibodies
Antibodies
Antibodies
Entity Primary SIC Number
Schedule of Estimated Term of Asset
Disclosure Of Estimated Term Of Asset Explanatory [Text Block]
Disclosure of estimated term of asset explanatory.
Common stock aggregate gross sales price
Common stock aggregate gross sales price
Common stock aggregate gross sales price
Finder's Warrants
Finders Warrants [Member]
Finders warrants.
Auditor Location
Conversion to shares
Shares issued pursuant to conversion of convertible debentures
Issue of convertible instruments
Issue of convertible debentures
Automobile
Vehicles [member]
Warrant exercisable price
Class Of Warrant Exercisable Price
Class of warrant exercisable price.
Deferred income taxes
Adjustments for deferred tax expense
Grant income
Income from government grants
Deferred tax assets
Deferred tax assets
Deferred tax asset
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Disclosure of subsidiaries [line items]
Period [Domain]
Period.
Cash and Cash Equivalents
Description of accounting policy for restricted cash and cash equivalents [text block]
Entity Interactive Data Current
Loss before income taxes
Profit (loss) before income taxes
Profit (loss) before income taxes.
Asset Impairment
Asset Impairment
Asset impairment
Amounts Receivable
Amounts Receivable [Member]
Amounts receivable.
Convertible debentures
Increase (decrease) through conversion of convertible instruments, equity
Management fees
Key Management Personnel Compensation Management Fees
Key management personnel compensation management fees.
ACQUISITION OF BIOSTRAND
Disclosure of business combinations [text block]
Schedule of changes in the Value of the Right-of-Use Assets
Disclosure of quantitative information about right-of-use assets [text block]
Schedule of Changes in the Value of Right-of-Use Assets
Presentation of leases for lessee [abstract]
Acquisition of BioStrand
Amortization
Acquisitions through business combinations, intangible assets other than goodwill
Disclosure of classes of share capital [abstract]
Share Capital
Issued capital [member]
Entity Tax Identification Number
Government grant
Description of accounting policy for government grants [text block]
Later than four years and not later than five years [member]
2031
The entire disclosure for significant accounting policies applied by the entity.
Disclosure for Summary of Significant Accounting Policies [Explanatory]
MATERIAL ACCOUNTING POLICIES
Leases
Leases
Leases Noncurrent
Leases noncurrent.
Resource Properties
Resource properties.
Resource properties
Weighted average life remaining (years)
Weighted average remaining contractual life of outstanding share options
Accumulated Other Comprehensive Income Loss
Accumulated other comprehensive income (loss).
Accumulated other comprehensive income loss
Accumulated other comprehensive income
Three Years [Member]
Three years.
Idea Family BV
Idea Family B V [Member]
Idea Family B V.
Local Phone Number
Number of underwritten public offering shares.
Number Of Underwritten Public Offering Shares
Number of underwritten public offering shares
Intangible assets
Description of accounting policy for intangible assets other than goodwill [text block]
Auditor Opinion [Text Block]
Less: Current portion
Current Deferred Cash Payments
Current deferred cash payments.
Number Of Warrants Expired
Number of warrants expired
Expired, Number of warrants
Disclosure of changes in restricted stock units explanatory [text block]
Disclosure of changes in restricted stock units explanatory.
Summarizes Activity Related to RSUs
Employee benefits expense
Total employee benefits expense
Employee benefits expense
BioStrand One [Member]
BioStrand.
BioStrand
ImmunoPrecise Antibodies (MA) LLC
Immuno Precise Antibodies M A L L C [Member]
ImmunoPrecise Antibodies (MA) LLC.
Adjustments to reconcile profit (loss) [abstract]
Adjustments not affecting cash:
Grant From Government [Member]
Grant From Government
Total current assets
Current assets
Liabilities arising from financing activities [axis]
Liabilities arising from financing activities [axis]
Option Six [Member]
Option six.
Option Expiry Date January 19, 2029
Option 6
Expiry Date
Warrants Outstanding Expiry Date
Warrants outstanding expiry date.
CAPITAL MANAGEMENT
Disclosure of objectives, policies and processes for managing capital [text block]
Disclosure of information for cash-generating units [line items]
Entity Emerging Growth Company